Neuroimaging biomarkers for Alzheimer's disease

F Márquez, MA Yassa - Molecular neurodegeneration, 2019‏ - Springer
Currently, over five million Americans suffer with Alzheimer's disease (AD). In the absence of
a cure, this number could increase to 13.8 million by 2050. A critical goal of biomedical …

Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease

R De Flores, R La Joie, G Chételat - Neuroscience, 2015‏ - Elsevier
Hippocampal atrophy, as evidenced using magnetic resonance imaging (MRI), is one of the
most validated, easily accessible and widely used biomarkers of Alzheimer's disease (AD) …

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

RS Desikan, F Ségonne, B Fischl, BT Quinn… - Neuroimage, 2006‏ - Elsevier
In this study, we have assessed the validity and reliability of an automated labeling system
that we have developed for subdividing the human cerebral cortex on magnetic resonance …

Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate

RL Buckner - Neuron, 2004‏ - cell.com
Memory decline in aging results from multiple factors that influence both executive function
and the medial temporal lobe memory system. In advanced aging, frontal-striatal systems …

A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability …

RL Buckner, D Head, J Parker, AF Fotenos, D Marcus… - Neuroimage, 2004‏ - Elsevier
Atlas normalization, as commonly used by functional data analysis, provides an automated
solution to the widely encountered problem of correcting for head size variation in regional …

High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic mild cognitive impairment

MA Yassa, SM Stark, A Bakker, MS Albert, M Gallagher… - Neuroimage, 2010‏ - Elsevier
Functional magnetic resonance imaging (fMRI) studies have observed hyperactivity in the
hippocampal region in individuals with Mild Cognitive Impairment (MCI). However, the …

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

M Ewers, C Walsh, JQ Trojanowski, LM Shaw… - Neurobiology of …, 2012‏ - Elsevier
The current study tested the accuracy of primary MRI and cerebrospinal fluid (CSF)
biomarker candidates and neuropsychological tests for predicting the conversion from mild …

Map** hippocampal and ventricular change in Alzheimer disease

PM Thompson, KM Hayashi, GI De Zubicaray… - Neuroimage, 2004‏ - Elsevier
We developed an anatomical map** technique to detect hippocampal and ventricular
changes in Alzheimer disease (AD). The resulting maps are sensitive to longitudinal …

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps

LG Apostolova, RA Dutton, ID Dinov… - Archives of …, 2006‏ - jamanetwork.com
Background While most patients with mild cognitive impairment (MCI) transition to Alzheimer
disease (AD), others develop non-AD dementia, remain in the MCI state, or improve …

Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging

E Gerardin, G Chételat, M Chupin, R Cuingnet… - Neuroimage, 2009‏ - Elsevier
We describe a new method to automatically discriminate between patients with Alzheimer's
disease (AD) or mild cognitive impairment (MCI) and elderly controls, based on …